Intuitive Surgical Inc (ISRG)vsDentsply Sirona Inc (XRAY)
ISRG
Intuitive Surgical Inc
$469.98
-0.41%
HEALTHCARE · Cap: $167.61B
XRAY
Dentsply Sirona Inc
$11.68
+1.88%
HEALTHCARE · Cap: $2.33B
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 173% more annual revenue ($10.06B vs $3.68B). ISRG leads profitability with a 28.4% profit margin vs -16.3%. XRAY appears more attractively valued with a PEG of 0.77. ISRG earns a higher WallStSmart Score of 62/100 (C+).
ISRG
Buy62
out of 100
Grade: C+
XRAY
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.8%
Fair Value
$262.88
Current Price
$469.98
$207.10 premium
Intrinsic value data unavailable for XRAY.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 30.2%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.8% revenue growth
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Trading at 9.4x book value
Premium valuation, high expectations priced in
Operating margin of 1.8%
ROE of -36.4% — below average capital efficiency
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 30.2%. Revenue growth of 18.8% demonstrates continued momentum.
Bull Case : XRAY
The strongest argument for XRAY centers on PEG Ratio, Price/Book. PEG of 0.77 suggests the stock is reasonably priced for its growth.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, Price/Book, P/E Ratio. A P/E of 59.9x leaves little room for execution misses.
Bear Case : XRAY
The primary concerns for XRAY are Operating Margin, Return on Equity, Profit Margin.
Key Dynamics to Monitor
ISRG profiles as a growth stock while XRAY is a turnaround play — different risk/reward profiles.
ISRG carries more volatility with a beta of 1.68 — expect wider price swings.
ISRG is growing revenue faster at 18.8% — sustainability is the question.
ISRG generates stronger free cash flow (730M), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (62/100 vs 56/100), backed by strong 28.4% margins and 18.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Dentsply Sirona Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?